Società Italiana per lo Studio delle Cefalee | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment	Headache, Headache Disorders, Secondary, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, migraine with aura, migraine without aura, nervous system disorder	Recruiting	Not stated	2026-06-11		NCT06409832
The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)	Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder	Recruiting	Not stated	2026-01-21		NCT06628921
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients	Headache, Headache Disorders, Secondary, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, migraine with aura, migraine without aura, nervous system disorder	Active, not recruiting	Not stated	2026-01-21		NCT06414044
Gepant treAtments: EffectIveNess and tolERability (GAINER)	Headache, Headache Disorders, Secondary, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, migraine with aura, migraine without aura, nervous system disorder	Recruiting	Not stated	2026-01-21		NCT05903027